Can-Fite BioPharma
  • ABOUT
    • Overview
    • Management
    • Drug Development Team
    • Board of Directors
    • Corporate Partnerships
  • SCIENCE
    • Technology Platform
    • Scientific Publications
  • PIPELINE
    • Overview
    • Piclidenoson (CF101)
    • Namodenoson (CF102)
    • CF602
    • Cannabinoids
  • INVESTORS
    • Overview
    • News & Events
    • Company Information
    • Financial Information
    • Stock Information
    • SEC Fillings
    • Corporate Governance
    • Shareholders Meetings
  • CONTACT

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • In The News
    • Research
    • Events Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Overview
    • Video
    • Management
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Governance Documents
  • Shareholders Meetings
  • News & Events

  • Overview
  • Press Releases
  • In The News
  • Research
  • Events Calendar
  • Presentations
  • Email Alerts
Jul 29, 2015 7:00am EDT

World Health Organization Accepted "Piclidenoson" as Proposed New Generic Name for Can-Fite's Lead Drug Candidate CF101

Jul 23, 2015 7:00am EDT

Can-Fite Joins Israeli Life Sciences Delegation to Japan on July 28 - 30, 2015

Jun 29, 2015 7:00am EDT

Can-Fite's CF602 Sexual Dysfunction Drug Backed by New Preclinical Data Progresses Towards an IND

Jun 19, 2015 7:00am EDT

Can-Fite Subsidiary OphthaliX Signs Definitive Agreement to Acquire Improved Vision Systems Ltd.

Jun 15, 2015 7:00am EDT

Can-Fite to Exhibit at Bio International Convention in Philadelphia on June 15 - 18, 2015

Jun 10, 2015 7:00am EDT

Can-Fite Granted Notice of Allowance for Patent Covering Manufacturing Process of CF101 in the U.S.

May 29, 2015 7:00am EDT

Can-Fite Reports First Quarter 2015 Results

May 11, 2015 7:00am EDT

Can-Fite's Phase II Liver Cancer Trial Approved in Europe

May 04, 2015 8:50am EDT

Can-Fite subsidiary, OphthaliX, Signs Term Sheet to Acquire Improved Vision Systems Ltd.

Apr 27, 2015 7:00am EDT

Can-Fite Reports Positive Results from Further Analysis of Phase II/III Psoriasis Trial

  • arrow_back
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 45
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • HOME
  • CONTACT

© 2025 Can-Fite All Rights Reserved

BrandWiz - Branding